Daewoong Pharma (069620) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Based on the latest financial reports, Daewoong Pharma (069620) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩57.53 Billion ≈ $38.99 Million USD) by net assets (₩1.00 Trillion ≈ $680.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Daewoong Pharma stock valuation for the company's overall valuation and market capitalisation.

Daewoong Pharma - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Daewoong Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Daewoong Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daewoong Pharma ranked by their cash flow conversion efficiency. Explore 069620 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Shanghai Geoharbour Construction Group Co Ltd SHG:605598	0.032x
Dynamatic Technologies Limited NSE:DYNAMATECH	0.068x
Shandong Ruifeng Chemical Co Ltd SHE:300243	-0.005x
Nick Scali Ltd AU:NCK	0.301x
Yunding Technology Co Ltd SHE:000409	-0.041x
Virtus Investment Partners, Inc. NYSE:VRTS	N/A
G R Infraprojects Limited NSE:GRINFRA	0.043x
Henan Hengxing Science & Technology Co Ltd SHE:002132	0.017x

Annual Cash Flow Conversion Efficiency for Daewoong Pharma (2007–2024)

The table below shows the annual cash flow conversion efficiency of Daewoong Pharma from 2007 to 2024. View Daewoong Pharma stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩926.98 Billion ≈ $628.20 Million	₩51.49 Billion ≈ $34.90 Million	0.056x	-66.35%
2023-12-31	₩802.97 Billion ≈ $544.16 Million	₩132.57 Billion ≈ $89.84 Million	0.165x	+3.52%
2022-12-31	₩741.22 Billion ≈ $502.32 Million	₩118.21 Billion ≈ $80.11 Million	0.159x	+180.10%
2021-12-31	₩702.41 Billion ≈ $476.01 Million	₩39.99 Billion ≈ $27.10 Million	0.057x	-60.80%
2020-12-31	₩695.25 Billion ≈ $471.16 Million	₩100.98 Billion ≈ $68.43 Million	0.145x	+60.35%
2019-12-31	₩635.92 Billion ≈ $430.95 Million	₩57.60 Billion ≈ $39.03 Million	0.091x	+15.90%
2018-12-31	₩607.81 Billion ≈ $411.90 Million	₩47.50 Billion ≈ $32.19 Million	0.078x	-52.52%
2017-12-31	₩631.54 Billion ≈ $427.98 Million	₩103.94 Billion ≈ $70.44 Million	0.165x	+547.03%
2016-12-31	₩604.55 Billion ≈ $409.70 Million	₩15.38 Billion ≈ $10.42 Million	0.025x	-58.87%
2015-12-31	₩580.24 Billion ≈ $393.22 Million	₩35.89 Billion ≈ $24.32 Million	0.062x	+8.59%
2014-12-31	₩455.51 Billion ≈ $308.69 Million	₩25.95 Billion ≈ $17.58 Million	0.057x	-53.94%
2013-12-31	₩437.96 Billion ≈ $296.80 Million	₩54.16 Billion ≈ $36.70 Million	0.124x	+6.17%
2012-12-31	₩386.59 Billion ≈ $261.98 Million	₩45.02 Billion ≈ $30.51 Million	0.116x	-46.45%
2011-12-31	₩362.42 Billion ≈ $245.60 Million	₩78.82 Billion ≈ $53.42 Million	0.217x	+93.60%
2008-12-31	₩278.85 Billion ≈ $188.97 Million	₩31.33 Billion ≈ $21.23 Million	0.112x	+17.33%
2007-12-31	₩269.57 Billion ≈ $182.68 Million	₩25.81 Billion ≈ $17.49 Million	0.096x	--

About Daewoong Pharma

KO:069620 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$867.88 Million

₩1.28 Trillion KRW

Market Cap Rank

#9547 Global

#253 in Korea

Share Price

₩111300.00

Change (1 day)

+2.20%

52-Week Range

₩107300.00 - ₩194000.00

All Time High

₩272265.92